Literature DB >> 7532231

Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism.

S V Yalla1, M P Sullivan, H S Lecamwasam, C E DuBeau, M A Vickers, E G Cravalho.   

Abstract

The precise role of the American Urological Association (AUA) symptom index in the management of benign prostatic hyperplasia (BPH) is not well established. The AUA symptom index has been recommended only for quantifying the symptoms of BPH but not for its diagnosis. However, to our knowledge the ability to discriminate obstructive from nonobstructive BPH using the AUA symptom index has never been investigated. To establish the relationship between the AUA symptom index and prostatic obstruction 125 men (mean age 67.7 +/- 8.4 years) with voiding dysfunction presumably related to BPH were analyzed. Patients were given the AUA symptom questionnaire, following which video urodynamic studies were done, including micturitional urethral pressure profilometry for specifically diagnosing outlet obstruction. The patients were divided into 2 groups: group 1-78 with primary BPH dysfunction and group 2-47 with prostatism of ambiguous etiology. The mean AUA symptom index in group 1 (15.5 +/- 7.1) was not statistically different from that in group 2 (14.8 +/- 7.9). In both groups the mean AUA symptom index in the patients with obstruction (15.3 +/- 7.2 for group 1 and 13.9 +/- 7.9 for group 2) was not statistically different from that in the nonobstructed group (17.0 +/- 5.4 and 16.1 +/- 7.9, respectively). Of the severely symptomatic patients 22% did not have obstruction whereas all mildly symptomatic patients did. No significant correlations were found between the severity of obstruction and the AUA symptom index in either group. These observations indicate that the AUA symptom index cannot discriminate obstructed from nonobstructed BPH cases, not all severely symptomatic BPH patients will have outlet obstruction, a significant proportion of mildly symptomatic BPH patients can have outlet obstruction and voiding dysfunctions in elderly men, regardless of the etiology, produce similar symptoms.

Entities:  

Mesh:

Year:  1995        PMID: 7532231

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

1.  Prediction of unfavourable symptomatic outcome of transurethral prostatectomy in patients with the relative indication for operation.

Authors:  I Ignjatovic
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

Review 2.  Targeting phenotypic heterogeneity in benign prostatic hyperplasia.

Authors:  Douglas W Strand; Daniel N Costa; Franto Francis; William A Ricke; Claus G Roehrborn
Journal:  Differentiation       Date:  2017-08-04       Impact factor: 3.880

Review 3.  Role of interleukins, IGF and stem cells in BPH.

Authors:  Ian D McLaren; Travis J Jerde; Wade Bushman
Journal:  Differentiation       Date:  2011-08-23       Impact factor: 3.880

Review 4.  Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction.

Authors:  Michael R Ruggieri; Alan S Braverman; Michel A Pontari
Journal:  J Urol       Date:  2005-11       Impact factor: 7.450

5.  Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction.

Authors:  Victor W Nitti
Journal:  Rev Urol       Date:  2005

6.  Evaluating men with benign prostatic hyperplasia.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2004

7.  Bladder outlet obstruction: etiology and evaluation.

Authors:  Roger R Dmochowski
Journal:  Rev Urol       Date:  2005

8.  The American Urological Association Symptom Index: early postoperative evaluation of irritative and obstructive symptoms due to benign prostatic hyperplasia.

Authors:  O Ichiyanagi; M Ishigooka; T Hashimoto; S Hayani; Y Suzuki; T Nakada
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

9.  Efficacy of tolterodine in preventing urge incontinence immediately after prostatectomy.

Authors:  Dionisios Mitropoulos; Stefanos Papadoukakis; Anastasios Zervas; Christos Alamanis; Aris Giannopoulos
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

10.  Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction.

Authors:  Petros Sountoulides; Marleen M van Dijk; Hessel Wijkstra; Jean J M C H de la Rosette; Martin Christian Michel
Journal:  World J Urol       Date:  2009-10-09       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.